Sigyn Therapeutics Statistics
Total Valuation
SIGY has a market cap or net worth of 6.42 million. The enterprise value is 8.99 million.
| Market Cap | 6.42M |
| Enterprise Value | 8.99M |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SIGY has 1.61 million shares outstanding. The number of shares has increased by 25.86% in one year.
| Current Share Class | 1.61M |
| Shares Outstanding | 1.61M |
| Shares Change (YoY) | +25.86% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 65.17% |
| Owned by Institutions (%) | n/a |
| Float | 373,019 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -1.18 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.34 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -773.69% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 42.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -959,873 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.43% in the last 52 weeks. The beta is -0.83, so SIGY's price volatility has been lower than the market average.
| Beta (5Y) | -0.83 |
| 52-Week Price Change | -30.43% |
| 50-Day Moving Average | 4.50 |
| 200-Day Moving Average | 7.57 |
| Relative Strength Index (RSI) | 45.00 |
| Average Volume (20 Days) | 1,446 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.30M |
| Pretax Income | -3.84M |
| Net Income | -3.84M |
| EBITDA | -2.30M |
| EBIT | -2.30M |
| Earnings Per Share (EPS) | -2.53 |
Balance Sheet
The company has 459 in cash and 2.57 million in debt, giving a net cash position of -2.57 million or -1.60 per share.
| Cash & Cash Equivalents | 459 |
| Total Debt | 2.57M |
| Net Cash | -2.57M |
| Net Cash Per Share | -1.60 |
| Equity (Book Value) | -5.44M |
| Book Value Per Share | -3.39 |
| Working Capital | -5.49M |
Cash Flow
| Operating Cash Flow | -900,912 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SIGY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.86% |
| Shareholder Yield | n/a |
| Earnings Yield | -59.79% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 31, 2024. It was a reverse split with a ratio of 0.025.
| Last Split Date | Jan 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |